Acumetis
  • Home
  • About Us
    • About Us Overview
      • ESG
    • Acumetis Launches as a Single Integrated Brand
  • Expertise
    • Expertise Overview
      • Commercial Strategy
      • Launch Excellence
      • Patient Access & Support Services
      • Global Value & Access
      • Insights & Analytics
      • Medical Affairs
    • Meet Acumetis at Fierce Pharma week 2026
  • Resources
    • Topics
      • Most Favored Nation
      • Direct-to-Patient
    • Resources Overview
      • Articles
      • Case Studies
      • Policy
      • Assessments
      • Trends
    • Implications for Evidence Strategy in Europe
  • Careers
Contact Us
Acumetis
  • Home
  • About Us
    • About Us Overview
      • ESG
    • Acumetis Launches as a Single Integrated Brand
  • Expertise
    • Expertise Overview
      • Commercial Strategy
      • Launch Excellence
      • Patient Access & Support Services
      • Global Value & Access
      • Insights & Analytics
      • Medical Affairs
    • Meet Acumetis at Fierce Pharma week 2026
  • Resources
    • Topics
      • Most Favored Nation
      • Direct-to-Patient
    • Resources Overview
      • Articles
      • Case Studies
      • Policy
      • Assessments
      • Trends
    • Implications for Evidence Strategy in Europe
  • Careers
Contact Us
Ali Soroush

Ali Soroush

Manager, Global Innovation

Biography

About

Back to Expertise
Authored Posts

Published works and authored insights

June 17, 2026
How to navigate loss of exclusivity with a strategic commercial playbook
Download the playbook to learn how leading organizations prepare for and manage loss of exclusivity.
Two nurses filling prescriptions in pharmacy
May 26, 2026
The “direct” continuum: Decoding direct-to-patient and direct-to-employer for commercial success
Explore how DTP and DTE models are reshaping commercialization, improving patient access, affordability, engagement, and market strategy.
Blurry photo of people walking across crosswalk
April 6, 2026
Why direct-to-patient is not one-size-fits-all
Explore scalable direct-to-patient (DTP) models that improve affordability, time-to-therapy, and patient engagement with a strategic, data-driven approach.
Man on laptop with apple at desk
April 3, 2026
Direct-to-patient (DTP) readiness assessment
We created a direct-to-patient (DTP) readiness assessment tool that distills complex market and patient dynamics into a clear readiness signal. This fact based tool enables you to assess your product...

Transform insight into action today

Connect with our team to tackle your toughest life sciences challenges with clarity, speed, and measurable impact.

Contact us
Acumetis Logo
Reframe
what's
possible.
Contact Us
Navigation
  • About Us
  • Expertise
  • Careers
  • ESG
  • Privacy Policy
  • Cookies Policy
Copyright © 2026 Acumetis. All rights reserved.